McRae Capital Management’s Amgen AMGN Stock Holding History

McRae Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$429K	Hold	1,186	–	–	0.08%	76
2026 Q1	$417K	Hold	1,186	–	–	0.09%	80
2025 Q4	$388K	Hold	1,186	–	–	0.08%	82
2025 Q3	$335K	Hold	1,186	–	–	0.07%	88
2025 Q2	$331K	Hold	1,186	–	–	0.07%	86
2025 Q1	$369K	Sell	1,186 -309	-21%	-$91.2K	0.08%	75
2024 Q4	$390K	Sell	1,495 -500	-25%	-$148K	0.08%	73
2024 Q3	$643K	Sell	1,995 -391	-16%	-$128K	0.13%	59
2024 Q2	$746K	Hold	2,386	–	–	0.17%	51
2024 Q1	$678K	Sell	2,386 -160	-6%	-$46.8K	0.15%	57
2023 Q4	$733K	Sell	2,546 -30	-1%	-$8.17K	0.18%	51
2023 Q3	$692K	Buy	2,576 +245	+11%	+$61.1K	0.21%	51
2023 Q2	$518K	Hold	2,331	–	–	0.15%	57
2023 Q1	$564K	Hold	2,331	–	–	0.16%	53
2022 Q4	$612K	Hold	2,331	–	–	0.18%	53
2022 Q3	$525K	Sell	2,331 -9	-0.4%	-$2.18K	0.16%	57
2022 Q2	$569K	Buy	2,340 +95	+4%	+$23.3K	0.15%	58
2022 Q1	$543K	Hold	2,245	–	–	0.12%	64
2021 Q4	$505K	Hold	2,245	–	–	0.11%	68
2021 Q3	$477K	Hold	2,245	–	–	0.11%	68
2021 Q2	$547K	Buy	2,245 +9	+0.4%	+$2.21K	0.13%	63
2021 Q1	$556K	Hold	2,236	–	–	0.14%	61
2020 Q4	$514K	Hold	2,236	–	–	0.15%	59
2020 Q3	$568K	Hold	2,236	–	–	0.19%	56
2020 Q2	$527K	Hold	2,236	–	–	0.2%	54
2020 Q1	$453K	Hold	2,236	–	–	0.22%	47
2019 Q4	$539K	Buy	2,236 +750	+50%	+$165K	0.2%	57
2019 Q3	$288K	Hold	1,486	–	–	0.11%	76
2019 Q2	$274K	Buy	1,486 +248	+20%	+$44.4K	0.11%	73
2019 Q1	$235K	Sell	1,238 -25	-2%	-$4.77K	0.1%	82
2018 Q4	$246K	Sell	1,263 -100	-7%	-$19.5K	0.13%	77
2018 Q3	$283K	Sell	1,363 -1,500	-52%	-$296K	0.12%	78
2018 Q2	$528K	Buy	2,863 +1,525	+114%	+$270K	0.22%	55
2018 Q1	$228K	Sell	1,338 -25	-2%	-$4.59K	0.1%	82
2017 Q4	$237K	Buy	+1,363	New	+$241K	0.1%	81
2015 Q3	–	Sell	-2,500	Closed	-$384K	–	75
2015 Q2	$384K	Hold	2,500	–	–	0.18%	53
2015 Q1	$400K	Sell	2,500 -19	-0.8%	-$2.99K	0.18%	54
2014 Q4	$401K	Buy	2,519 +19	+0.8%	+$2.96K	0.19%	54
2014 Q3	$351K	Hold	2,500	–	–	0.17%	55
2014 Q2	$296K	Hold	2,500	–	–	0.14%	62
2014 Q1	$308K	Hold	2,500	–	–	0.16%	60
2013 Q4	$285K	Sell	2,500 -120	-5%	-$13.7K	0.15%	62
2013 Q3	$293K	Sell	2,620 -700	-21%	-$75.9K	0.16%	56
2013 Q2	$328K	Buy	+3,320	New	+$345K	0.19%	52

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

McRae Capital Management's AMGN Position: Q2 2026 in Review

McRae Capital Management held its Amgen (AMGN) position steady in Q2 2026 at 1,186 shares worth $429K. The position accounts for 0.08% of the portfolio, ranked #76.

McRae Capital Management first reported a position in AMGN in Q2 2013 and has held it in 44 quarters since. The position peaked at $746K in Q2 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

McRae Capital Management held 1,186 shares of Amgen worth $429K as of Q2 2026.
McRae Capital Management left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.08% of McRae Capital Management's portfolio in Q2 2026, its #76 holding.
McRae Capital Management first reported a position in Amgen in Q2 2013 and has held it in 44 quarters since.
McRae Capital Management's Amgen position peaked at $746K in Q2 2024.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on McRae Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.